Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 2, Pages 468-474Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI44595
Keywords
-
Categories
Ask authors/readers for more resources
Epithelial-mesenchymal transition (EMT) has become widely accepted as a mechanism by which injured renal tubular cells transform into mesenchymal cells that contribute to the development of fibrosis in chronic renal failure. However, an increasing number of studies raise doubts about the existence of this process in vivo. Herein, we review and summarize both sides of this debate, but it is our view that unequivocal evidence supporting EMT as an in vivo process in kidney fibrosis is lacking.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available